Geode Capital Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.48B Buy
28,736,341
+856,860
+3% +$82.1M 0.15% 111
2025
Q4
$2.67B Buy
27,879,481
+231,919
+0.8% +$22.5M 0.16% 97
2025
Q3
$2.62B Sell
27,647,562
-579,444
-2% -$53.3M 0.17% 99
2025
Q2
$2.45B Buy
28,227,006
+310,684
+1% +$26.3M 0.17% 100
2025
Q1
$2.5B Buy
27,916,322
+860,105
+3% +$77M 0.2% 91
2024
Q4
$2.16B Buy
27,056,217
+574,055
+2% +$49.7M 0.17% 98
2024
Q3
$2.38B Sell
26,482,162
-374,827
-1% -$31.5M 0.19% 91
2024
Q2
$2.11B Buy
26,856,989
+210,063
+0.8% +$17.2M 0.19% 93
2024
Q1
$2.32B Sell
26,646,926
-80,604
-0.3% -$6.88M 0.21% 80
2023
Q4
$2.2B Buy
26,727,530
+423,713
+2% +$32.3M 0.23% 77
2023
Q3
$2.06B Buy
26,303,817
+684,668
+3% +$57.3M 0.25% 69
2023
Q2
$2.25B Sell
25,619,149
-575,779
-2% -$49.6M 0.26% 65
2023
Q1
$2.11B Sell
26,194,928
-1,027,372
-4% -$83.7M 0.27% 65
2022
Q4
$2.11B Buy
27,222,300
+423,715
+2% +$34.3M 0.3% 66
2022
Q3
$2.16B Buy
26,798,585
+266,802
+1% +$24M 0.33% 50
2022
Q2
$2.38B Buy
26,531,783
+963,333
+4% +$97.6M 0.35% 52
2022
Q1
$2.83B Buy
25,568,450
+3,073,909
+14% +$325M 0.35% 48
2021
Q4
$2.32B Buy
22,494,541
+321,333
+1% +$37.2M 0.28% 63
2021
Q3
$2.77B Buy
22,173,208
+360,078
+2% +$46.6M 0.37% 47
2021
Q2
$2.7B Buy
21,813,130
+381,458
+2% +$47.9M 0.37% 46
2021
Q1
$2.52B Buy
21,431,672
+401,564
+2% +$47.1M 0.39% 43
2020
Q4
$2.46B Buy
21,030,108
+400,530
+2% +$44.1M 0.41% 44
2020
Q3
$2.14B Buy
20,629,578
+204,512
+1% +$20.5M 0.42% 42
2020
Q2
$1.87B Buy
20,425,066
+97,941
+0.5% +$9.39M 0.4% 45
2020
Q1
$1.83B Buy
20,327,125
+639,833
+3% +$68.1M 0.48% 38
2019
Q4
$2.23B Buy
19,687,292
+1,225,925
+7% +$135M 0.47% 36
2019
Q3
$2B Buy
18,461,367
+561,127
+3% +$58.5M 0.47% 34
2019
Q2
$1.74B Buy
17,900,240
+371,727
+2% +$33.9M 0.42% 41
2019
Q1
$1.59B Buy
17,528,513
+838,306
+5% +$75M 0.41% 44
2018
Q4
$1.52B Buy
16,690,207
+1,538,130
+10% +$144M 0.47% 36
2018
Q3
$1.49B Buy
15,152,077
+153,184
+1% +$14.2M 0.42% 42
2018
Q2
$1.28B Buy
14,998,893
+2,825
+0% +$236K 0.39% 48
2018
Q1
$1.2B Buy
14,996,068
+804,393
+6% +$66.3M 0.39% 50
2017
Q4
$1.14B Buy
14,191,675
+351,256
+3% +$28.1M 0.39% 46
2017
Q3
$1.07B Buy
13,840,419
+383,281
+3% +$31.8M 0.4% 47
2017
Q2
$1.19B Buy
13,457,138
+148,326
+1% +$12.5M 0.47% 37
2017
Q1
$1.07B Buy
13,308,812
+906,581
+7% +$70.8M 0.44% 39
2016
Q4
$882M Buy
12,402,231
+421,590
+4% +$33.1M 0.41% 43
2016
Q3
$1.03B Buy
11,980,641
+334,514
+3% +$29.1M 0.52% 33
2016
Q2
$1.01B Sell
11,646,127
-100,958
-0.9% -$8.16M 0.55% 35
2016
Q1
$879K Buy
11,747,085
+220,466
+2% +$16.6M 0.47% 41
2015
Q4
$885M Sell
11,526,619
-45,363
-0.4% -$3.41M 0.5% 38
2015
Q3
$773M Buy
11,571,982
+27,634
+0.2% +$2.04M 0.47% 39
2015
Q2
$854M Buy
11,544,348
+42,647
+0.4% +$3.26M 0.49% 40
2015
Q1
$896M Buy
11,501,701
+3,825,291
+50% +$290M 0.51% 38
2014
Q4
$554M Buy
7,676,410
+199,399
+3% +$13.9M 0.33% 59
2014
Q3
$463M Sell
7,477,011
-98,171
-1% -$6.24M 0.3% 65
2014
Q2
$483M Sell
7,575,182
-191,532
-2% -$11.6M 0.31% 62
2014
Q1
$478M Buy
7,766,714
+133,651
+2% +$7.79M 0.32% 58
2013
Q4
$438M Buy
7,633,063
+452,205
+6% +$25.6M 0.3% 67
2013
Q3
$382M Buy
7,180,858
+139,564
+2% +$7.51M 0.31% 65
2013
Q2
$362M Buy
+7,041,294
New +$348M 0.32% 62

Other funds holding MDT

Geode Capital Management's MDT Position: Q1 2026 in Review

Geode Capital Management increased its Medtronic (MDT) stake by 3.1% in Q1 2026, buying an estimated $82.1M and bringing the position to 28,736,341 shares worth $2.48B. The position accounts for 0.15% of the portfolio, ranked #111.

Geode Capital Management first reported a position in MDT in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.83B in Q1 2022. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Geode Capital Management held 28,736,341 shares of Medtronic worth $2.48B as of Q1 2026.
  • Geode Capital Management bought 856,860 Medtronic shares in Q1 2026, an estimated $82.1M.
  • Medtronic made up 0.15% of Geode Capital Management's portfolio in Q1 2026, its #111 holding.
  • Geode Capital Management first reported a position in Medtronic in Q2 2013 and has held it in 52 quarters since.
  • Geode Capital Management's Medtronic position peaked at $2.83B in Q1 2022.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.